The NFL says it will stop selling the category - which brings in $6million a year - after its three-year deal with GlaxoSmithKline's Levitra expires this year, reports Media Daily News.
Withdrawing the category won't prevent drug companies from advertising erectile dysfunction drugs on TV but the move is likely to lead to a drop in these revenues.
ED drugs had been looked at a growing category with upwards of $200million or more spent in advertising.
Congressmen, regulators and critics complained about ED advertising during the Super Bowl, something the NFL calls 'family' programming.
